Filing Details

Accession Number:
0000904454-23-000427
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-12 16:49:14
Reporting Period:
2023-07-10
Accepted Time:
2023-07-12 16:49:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590560 Uniqure N.v. QURE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867944 Pierre Caloz C/O Uniqure N.v.
Paasheuvelweg 25A
Amsterdam P7 11058BP
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-07-10 15,117 $11.36 95,098 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on March 10, 2023 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.26 to $11.49. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.